|Description||Terminal Illness Medication|
|Series C, 12/2007 |
Caxton Advantage Life Sciences Fund
Kleiner Perkins Caufield & Byers
Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Cortheraâ€™s lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.